Want to join the conversation?
Motion sensing products maker $DHR reported 2Q16 net earnings of $656.7MM or $0.94 per diluted share, down 5.6% versus $695.7MM or $0.97 per diluted share in 2Q15, hurt by higher cost of sales, operating expense, and income tax. Non-GAAP adjusted diluted net EPS rose 17% to $1.25 versus previous year.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.